戻る Agenda
[V4-S2] Bridging the Gap between Bio-ventures and the Pharmaceutical Industry to Form Drug-Making Partnerships
Session Chair(s)
Satoshi Toyoshima, PHD
Professor, Faculty of Pharmacy, Graduate School of Pharmaceutical Sciences
Musashino University, Japan
Kazumichi Kobayashi, RPH
Executive Deputy President (Board Member)
Otsuka Medical Devices Co., Ltd., Japan
Speaker(s)
Challenges in Building of the Ecosystem of Drug Discovery and Development
Koichi Ashida
Innovation Network Corporation of Japan, Japan
Managing Director
Who are Clients for Bio-Ventures?Impact of Changing Market Environment of Healthcare and Pharmaceutical on Growth on Bio-Venture
Tetsushi Inada, PHD
Pharma-East Insight, Inc., United States
President & Managing Director
Harness Innovation in Japan for Global Drug R&D: Opportunities, Challenges and Pfizer Approach
Shinji Ogawa, PHD
Pfizer Japan Inc., Japan
Senior Manager, Japan Portfolio & Project Management
Analysis of Perception Gap on Alliance Activities between Japanese Biotechnology Venture Companies and Pharmaceutical Companies
Masafumi Shimokawa
Japan